[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Seer Inc Cl A (SEER)

Seer Inc Cl A (SEER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,507
  • Shares Outstanding, K 56,421
  • Annual Sales, $ 16,580 K
  • Annual Income, $ -73,600 K
  • EBIT $ -78 M
  • EBITDA $ -71 M
  • 60-Month Beta 1.63
  • Price/Sales 6.40
  • Price/Cash Flow N/A
  • Price/Book 0.41

Options Overview Details

View History
  • Implied Volatility 295.74% (+5.04%)
  • Historical Volatility 48.80%
  • IV Percentile 79%
  • IV Rank 38.37%
  • IV High 686.21% on 04/15/26
  • IV Low 52.65% on 06/09/25
  • Expected Move (DTE 5) 0.0340 (1.82%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 31
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 363
  • Open Int (30-Day) 516
  • Expected Range 1.8360 to 1.9040

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.34
  • Growth Rate Est. (year over year) +293,923.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6650 +12.31%
on 04/09/26
2.0900 -10.53%
on 05/04/26
+0.1800 (+10.65%)
since 04/08/26
3-Month
1.6500 +13.33%
on 03/31/26
2.2000 -15.00%
on 02/20/26
+0.0800 (+4.47%)
since 02/06/26
52-Week
1.6500 +13.33%
on 03/31/26
2.4100 -22.41%
on 10/24/25
-0.0200 (-1.06%)
since 05/08/25

Most Recent Stories

More News
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer

Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph ® Product Suite REDWOOD CITY, Calif., May 04, 2026...

SEER : 1.8700 (-0.53%)
Seer to Report First Quarter 2026 Financial Results on May 13, 2026

REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial...

SEER : 1.8700 (-0.53%)
The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition Proposal

Emphasizes that Stockholders Cannot Trust CEO Omid Farokhzad, M.D. and the Incumbent Board to Create Value for Stockholders Based on Their Record of Chronic Financial Underperformance and Stockholder Value...

SEER : 1.8700 (-0.53%)
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group

REDWOOD CITY, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced...

SEER : 1.8700 (-0.53%)
The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.

Proposal Provides Stockholders $2.35 per Share in Cash, a 39% Premium to the Unaffected Closing Price, as Well as Potential Additional Value from the Sale of Seer’s Assets via a Contingent Value Right...

SEER : 1.8700 (-0.53%)
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed...

SEER : 1.8700 (-0.53%)
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.

Proposal Provides Stockholders $2.25 per Share in Cash, a 33% Premium to the Most Recent Closing Price, as Well as Potential Additional Value from the Sale of Seer’s Assets via a Contingent Value Right...

SEER : 1.8700 (-0.53%)
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

REDWOOD CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Proteograph ®...

SEER : 1.8700 (-0.53%)
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leader in deep, unbiased proteomic insights, today announced that the Patent Trial and Appeal Board (“PTAB”)...

SEER : 1.8700 (-0.53%)
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs

Raises Concerns About the Board’s Continued Deference to Chair and CEO Dr. Omid Farokhzad in Light of His Track Record of Value Destruction Highlights Recently Filed...

SEER : 1.8700 (-0.53%)

Business Summary

Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.

See More

Key Turning Points

3rd Resistance Point 1.9467
2nd Resistance Point 1.9233
1st Resistance Point 1.8967
Last Price 1.8700
1st Support Level 1.8467
2nd Support Level 1.8233
3rd Support Level 1.7967

See More

52-Week High 2.4100
Fibonacci 61.8% 2.1197
Fibonacci 50% 2.0300
Fibonacci 38.2% 1.9403
Last Price 1.8700
52-Week Low 1.6500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.